Yufei Liu, MD, PhD, discussed the importance of careful data interpretation to accurately assess the efficacy of new ...
Clearside eye disease candidate aces exam in pursuit of Roche's Vabysmo and Regeneron, Bayer's Eylea
A decade into reformulating Pfizer’s oral renal cell carcinoma drug Inlyta (axitinib) into a treatment that can be injected ...
GlobalData on MSN10h
4C Medical enrols first patients in pivotal mitral valve trialUS-based 4C Medical has enrolled the first patients in a pivotal trial for its transcatheter mitral valve replacement (TMVR) ...
Istaroxime is a novel first-in-class investigational therapy that is intended to improve systolic contraction and diastolic relaxation of the heart while also increasing blood pressure and maintaining ...
GlobalData on MSN12h
MSD’s Phase III trial of head and neck cancer treatment meets primary endpointKEYTRUDA’s safety profile in this trial was found to be in line with previous studies, without any new safety concerns ...
The FDA's Tala Fakhouri discusses the agency's approach to the regulation of AI in clinical trials in a new interview.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback